In recent years, the FDA approved two drugs—lecanemab and donanemab ... and delivery methods for dopamine-enhancing medications. Advances in technology, such as imaging tools to monitor ...

For example, therapies for addiction might aim to reduce dopamine activity while enhancing serotonin signaling ... our work could help explain why drugs that produce both dopamine and serotonin ...

"Amphetamines belong to a class of drugs called sympathomimetic amines or stimulants that cause the release of excitatory neurotransmitters, such as dopamine ... to the mood-enhancing properties ...

However, pharmacologically blocking of dopamine neurotransmission suppressed the blood pressure and heart rate changes induced by lateral habenula activation. Furthermore, these changes were also ...